The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Risk of cancer in women receiving hormone replacement therapy
Abstract
Cancer risk following treatment with non‐contraceptive estrogens was studied in a population‐based cohort of 23,244 women. Complete follow‐up for an average of 6.7 years revealed 1,087 incident cancers versus 962.5 expected (relative risk/RR/= 1.13; 95% confidence interval 1.10–1.20). We confirmed the recent findings of a more detailed analysis of the same cohort, based on a I‐year shorter follow‐up period, namely: a markedly increased risk of endometrial cancer (RR = 1.8; 1.5–2.1), notably in women receiving potent estrogens, i.e., conjugated estrogens or estradiol (RR = 2.0; 1.6–2.4), and a slightly increased risk of breast cancer (RR = 1.1; 1.0–1.2). A slightly decreased risk of invasive cervical cancer (RR = 0.8; 0.5–1.2) is most likely due to more frequent smear taking than in the background population. There was no increase in the risk of cancer of ovary (RR = 1.0; 0.8‐1.2), pancreas (RR = 0.8; 0.5–1.2), large bowel (RR = 1.0; 0.8–1.2) or kidney (RR = 1.0; 0.7–1.4). The risk of developing cancer in liver or biliary tract was lower than expected (RR = 0.4; 0.2–0.7), particularly in women who had used potent estrogens (RR = 0.3; 0.1–0.6), an unexpected finding which warrants further studies. Increased risks of malignant melanoma (RR = 1.5; 1.0–2.1) and lung cancer (RR = 1.3; 0.9–1.7) need cautious interpretation because of their low magnitude, the absence of a biological gradient when subgroups were analyzed and the slightly higher prevalence of smokers in the cohort than in the background population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Epidemiology and Prevention
(2006) · doi:10.1093/acprof:oso/9780195149616.001.0001 · Cited by 3,369
EPIDEMIOLOGY OF OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES
CUMMINGS, S. R., KELSEY, J. L., NEVITT, M. C., & O'DOWD, K. J. (1985) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036281 · Cited by 1,705
Cancer Epidemiology and Prevention.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-1-140_1 · Cited by 952
The Risk of Breast Cancer after Estrogen and Estrogen–Progestin Replacement
Bergkvist, L., Adami, H.-O., Persson, I., Hoover, R., & Schairer, C. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210505 · Cited by 613
Self-citationPersson, I., Adami, H. O., Bergkvist, L., Lindgren, A., Pettersson, B., Hoover, R., & Schairer, C. (1989) · BMJ · doi:10.1136/bmj.298.6667.147 · Cited by 403
Self-citationPancreas Cancer and Smoking, Beverage Consumption, and Past Medical History 2
(1986) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/76.1.49 · Cited by 362
Carcinogenicity of catechol estrogens in Syrian hamsters
Liehr, J. G., Wan-Fen, F., Sirbasku, D. A., & Ari-Ulubelen, A. (1986) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(86)90080-4 · Cited by 356
HUNT, K., VESSEY, M., MCPHERSON, K., & COLEMAN, M. (1987) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1987.tb03166.x · Cited by 288
Determinants of Ovarian Cancer Risk. I. Reproductive Experiences and Family History 23
(1983) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/71.4.711 · Cited by 256
Cited by
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
Grady, D., Rubin, S. M., Petitti, D. B., Fox, C. S., Black, D., Ettinger, B., Ernster, V. L., & Cummings, S. R. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-1016 · Cited by 2,336
Risk factors for lung cancer worldwide
Malhotra, J., Malvezzi, M., Negri, E., La Vecchia, C., & Boffetta, P. (2016) · European Respiratory Journal · doi:10.1183/13993003.00359-2016 · Cited by 980
Hormone replacement therapy and endometrial cancer risk: A meta-analysis
GRADY, D., GEBRETSADIK, T., KERLIKOWSKE, K., ERNSTER, V, & PETITTI, D. (1995) · Obstetrics & Gynecology · doi:10.1016/0029-7844(94)00383-o · Cited by 962
Colorectal Cancer: Molecules and Populations
Potter, J. D. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.11.916 · Cited by 881
Differences in Lung Cancer Risk Between Men and Women: Examination of the Evidence
Zang, E. A., & Wynder, E. L. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.3-4.183 · Cited by 722
Metadata
- Authors
- Adami, H., Persson, I., Hoover, R., Schairer, C., & Bergkvist, L.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1989-11-15
- Volume
- 44
- Issue
- 5
- Pages
- 833-839
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2011701047
- Cited by
- 267
- References
- 29
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk of cancer in women receiving hormone replacement therapy. https://app.cochat.ai/papers/10.1002/ijc.2910440515
- The paper
- Adami, H., Persson, I., Hoover, R., Schairer, C., & Bergkvist, L. (1989). Risk of cancer in women receiving hormone replacement therapy. International Journal of Cancer. https://doi.org/10.1002/ijc.2910440515
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.